mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.07 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.07 |